![Bryan Geoffrey Morton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bryan Geoffrey Morton
Fondateur chez
EUSA Pharma, Inc.
Profil
Mr. Bryan G.
Morton is an Operating Partner at Essex Woodlands Health Ventures UK Ltd., an Executive Chairman at EUSA Pharma (UK) Ltd., an Executive Chairman at EUSA Pharma, Inc., a Chairman at Aircraft Medical Ltd., a Chairman at EUSA Pharma SAS, a Chief Financial Officer at Perspectum Diagnostics Ltd., an Independent Non-Executive Chairman at HealthCare Royalty Trust PLC and a Non-Executive Chairman at VHsquared Ltd. He is on the Board of Directors at Syncona Partners LLP.
Mr. Morton was previously employed as a Non-Executive Chairman by Oxford BioTherapeutics Ltd., a President-International by Jazz Pharmaceuticals Plc, a Non-Executive Director by Dechra Pharmaceuticals PLC, a Non-Executive Chairman by Aircraft Medical Ltd., a Non-Executive Chairman by ReNeuron Group Plc, a Chief Executive Officer by Zeneus Pharma Ltd., a Senior Vice President & Director-Europe Region by Bristol-Myers Squibb Co., a President-EMEA by ConvaTec, Inc., a Chairman by Glide Pharmaceutical Technologies Ltd., and a General Manager & Head-Europe Division by Merck & Co., Inc. He also served on the board at Oxtex Ltd.
He received his undergraduate degree from the University of Aberdeen and an MBA from the University of Durham.
Postes actifs de Bryan Geoffrey Morton
| Sociétés | Poste | Début |
|---|---|---|
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Fondateur | 01/01/2006 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Président | 09/02/2010 |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Président | 01/01/2006 |
Essex Woodlands Health Ventures UK Ltd.
 Essex Woodlands Health Ventures UK Ltd. Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/01/2017 |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Private Equity Investor | - |
Anciens postes connus de Bryan Geoffrey Morton
| Sociétés | Poste | Fin |
|---|---|---|
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Directeur/Membre du Conseil | 02/01/2020 |
Perspectum Ltd.
 Perspectum Ltd. Medical/Nursing ServicesHealth Services Provides technology solutions for diagnosing and staging liver disease | Directeur Financier/CFO | 24/12/2016 |
| RENEURON GROUP PLC | Président | 01/04/2015 |
| DECHRA PHARMACEUTICALS | Directeur/Membre du Conseil | 09/07/2012 |
| ░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Bryan Geoffrey Morton
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Provides pharmaceutical products | Distribution Services |
ReNeuron Group Plc
 ReNeuron Group Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and manufactures cell-based therapy products | Health Technology |
EUSA Pharma, Inc.
EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and researches pharmaceutical products | Health Technology |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody-based medicines for oncology | Health Technology |
Aircraft Medical Ltd.
 Aircraft Medical Ltd. Medical SpecialtiesHealth Technology Develops and produces medical devices that focuses on the needs of anesthesia and critical care professionals | Health Technology |
Dechra Pharmaceuticals Ltd.
 Dechra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells veterinary pharmaceuticals | Health Technology |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ConvaTec, Inc.
 ConvaTec, Inc. Medical SpecialtiesHealth Technology Develops and manufactures products for the ostomy management, advanced chronic and acute wound care and continence care services | Health Technology |
University of Durham
 University of Durham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Essex Woodlands Management, Inc.
Essex Woodlands Management, Inc. Investment ManagersFinance EW Healthcare Partners invests in public and private companies located in the North America, Latin America, Asia, and Europe with revenues ranges from USD 20 - 200 million. The firm focuses on sectors such as pharmaceutical, medical device, healthcare services, and healthcare IT. The firm participates in growth capital requirements with an investment size range from USD 20 - 100 million. It takes minority or majority interest and requires a board position. | Finance |
Essex Woodlands Health Ventures UK Ltd.
Essex Woodlands Health Ventures UK Ltd. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Glide Pharmaceutical Technologies Ltd.
 Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology Specializes in pharmaceutical research for rare diseases | Health Technology |
Oxtex Ltd.
 Oxtex Ltd. Medical SpecialtiesHealth Technology Manufactures anisotropic self-inflating tissue expanders | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Perspectum Ltd.
Perspectum Ltd. Medical/Nursing ServicesHealth Services Provides technology solutions for diagnosing and staging liver disease | Health Services |
VHsquared Ltd.
 VHsquared Ltd. BiotechnologyHealth Technology Develops antibody domain products against gastro intestinal infectious and immune mediated diseases | Health Technology |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
EUSA Pharma (UK) Ltd.
EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services Supplies medicines and medical devices | Distribution Services |
HealthCare Royalty Trust PLC
 HealthCare Royalty Trust PLC Investment Trusts/Mutual FundsMiscellaneous Operates as a closed-ended investment fund | Miscellaneous |
Choisissez Zonebourse 
